SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT
NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.
- NEW YORK, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.
- If you are a shareholder who purchased Fulgent securities during the Class Period, you have until November 21, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
- To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
- Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.